NCT07276932 Clinical Study of Acupoint Application on Relieving qi Deficiency and Constipation in Patients Undergoing Chemotherapy
| NCT ID | NCT07276932 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Condition | Postoperative Chemotherapy |
| Study Type | INTERVENTIONAL |
| Enrollment | 106 participants |
| Start Date | 2025-07-16 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 106 participants in total. It began in 2025-07-16 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
4.1 Research Content 1. Clarifying the acupoint application scheme for deficiency and constipation in CRC patients undergoing chemotherapy: the preliminary acupoint application scheme for deficiency and constipation in CRC patients was formulated according to the systematic literature search, analysis of acupoint and traditional Chinese medicine prescription, analysis of meridian tropism of acupoints, Chinese herbal medicine taste and meridian tropism, etc., and multidisciplinary expert consultation. Through two rounds of Delphi expert letter consultation, the acupoint application scheme for deficiency and secret of CRC patients undergoing chemotherapy was determined. 2. Randomized controlled trials were conducted to compare the effect of acupoint application scheme and conventional treatment in improving constipation symptoms, total clinical efficacy, and improving patient comfort rate in CRC patients undergoing chemotherapy. 4.2 Key problems to be solved Based on the theory of "state-target dialectics", the analysis of acupoints and traditional Chinese medicine prescriptions, the analysis of meridian tropism of acupoints, the flavor and meridian tropism of Chinese herbs are used to select Chinese herbs that moisten the intestine and relieve defecation, strengthen the central and qi, and explore the acupoint application to provide a basis for more effective application of acupoint application in the treatment of qi deficiency and constipation in patients with CRC chemotherapy, form a generalized integrated Chinese and western medicine diagnosis and treatment plan, and promote the development of integrated Chinese and western medicine. 4.3 Expected Goals 1. Clarify the diagnosis and treatment plan of acupoint application in the treatment of qi deficiency and constipation in patients with colorectal cancer. 2. The flexible application of classic formula and scientific acupoint selection and sticking can effectively relieve qi deficiency and constipation in CRC patients undergoing chemotherapy, improve the total clinical efficacy and comfort of patients. It has been used in clinical practice and promoted to other medical institutions.
Eligibility Criteria
Inclusion Criteria: 1. Clinical diagnosis of colorectal cancer 2. Chemotherapy was performed after surgery 3. Diagnosis of qi deficiency and constipation 4. Age ≥18 years old Exclusion Criteria: 1. Clinical diagnosis of other digestive tract or anal organic diseases 2. Observed with severe cardiac, hepatic, renal insufficiency or other complications 3. Allergic constitution or allergy to a drug in constipation paste
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07276932 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Postoperative Chemotherapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07276932 currently recruiting?
Yes, NCT07276932 is actively recruiting participants. Contact the research team at 2201031@zju.edu.cn for enrollment information.
Where is the NCT07276932 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT07276932 clinical trial?
NCT07276932 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The trial plans to enroll 106 participants.